Image courtesy by QUE.com As we navigate the mid-point of the 2020s, the concept of health has undergone a fundamental ...

Tap Here To Add Us Weekly As A Trusted Source Add as a preferred source on Google Biohacking isn’t just a Silicon Valley side project anymore. It’s at the strip mall, the wellness chain down the block ...

It’s 7:35 a.m. inside Austin’s Fairmont Hotel when the elevator doors open and a fit, tanned man sporting a red-light therapy cap and yellow-tinted glasses steps into a packed, half-asleep car. “Are ...

Growing up alongside the rise of the commercialised internet sparked my interest in communication, technology, and power. As an undergraduate I worked as a peer tutor at the university’s writing ...

Intellia Therapeutics said its Crispr-based treatment for a rare swelling condition succeeded in a Phase 3 trial, a landmark for gene editing. The treatment uses Nobel Prize-winning Crispr technology ...

From hyperbaric chambers to AI-enabled talking dolls, journalist Kara Swisher separates longevity fact from fad on her new CNN series Kara Swisher Wants to Live Forever. “There are all these ...

Three days of forest bathing, cell-health analysis, floating saunas, clean eating, and AI-powered baristas in Bellevue, Washington. To really understand biohacking, though, you have to experience it ...

Your responses may be used in an article that examines the growing popularity of biohacking. By Priya Krishna There’s a word that has become inescapable in recent years: biohacking. It refers to the ...

Please tell us what changes you’ve made to your health and wellness practices to improve your brain function and job performance. We may include your experiences in an article. By Noam Scheiber See ...

Tech industry workers and founders are turning to imported peptides in an effort to optimize their physical and mental performance, says journalist Jasmine Suns. In an industry known for pushing the ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...